<DOC>
	<DOCNO>NCT00799487</DOCNO>
	<brief_summary>The purpose trial determine study medication , CONCERTA ( methylphenidate HCl ) , safe effective improve academic performance behavior child Attention Deficit Hyperactivity Disorder ( ADHD ) compare placebo .</brief_summary>
	<brief_title>CONCERTA Lab School Study</brief_title>
	<detailed_description>The hypothesis CONCERTA ( methylphenidate HCl ) safe effective improve academic performance behavior child ADHD compare placebo demonstrate use specify study measure . This double-blind ( neither participant investigator know name assign study drug ) , randomize ( study drug assign chance ) , placebo-controlled , crossover study evaluate academic , behavioral cognitive effect CONCERTA ( methylphenidate HCl ) old child ADHD This mean eligible child receive treatment methylphenidate HCl throughout study ( titration assessment period ) inactive pill ( placebo ) 1 2 laboratory classroom day . On laboratory classroom day receive regular dose CONCERTA ( methylphenidate HCl ) . The primary efficacy variable study Permanent Product Math Test ( PERMP ) attempt score . Secondary Measures include : SKAMP ( Swanson , Kotkin , Agler , M-Flynn , Pelham ) , test inattention , read fluency comprehension , memory . Assessments complete laboratory assessment day ( 12.5 hour ) . Participants assess adverse event throughout study . Patients initiate treatment oral CONCERTA ( methylphenidate HCl ) 18 mg baseline continue morning dosing increase every 3 7 day optimal dose achieve , maximum 54 mg/day . Eligible patient remain study maximum 8 week .</detailed_description>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>ADHD diagnosis subtypes ( except Not Otherwise Specified ) Patients total subscale Attention Deficit Hyperactivity Disorder Rating Scale ( ADHD RSIV ) score &gt; =90th percentile relative general population child age gender Patients currently receive ADHD medication must inadequately manage current stimulant dose meet criterion screen visit Ability read understand English Ability attend school regularly Estimated Full Scale IQ score 80 , Severe Learning Disability History current , primary diagnosis : severe anxiety disorder , conduct disorder , psychotic disorder , Pervasive Developmental Disorder , Eating Disorder , ObsessiveCompulsive Disorder , Sleep Disorder , Major Depressive Disorder , Bipolar Disorder , Substance Use Disorder , Chronic Tic Disorder , personal family history Tourette 's Syndrome Weight &lt; 3rd percentile age History hospitalization treatment mood , anxiety , psychotic disorder History fail response methylphenidate</criteria>
	<gender>All</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>ADHD</keyword>
	<keyword>Attention Deficit Hyperactivity Disorder</keyword>
</DOC>